Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy

BACKGROUND: Fabry disease (FD) is a treatable X-linked condition leading to progressive cardiac disease, arrhythmia and premature death. We aimed to increase awareness of the arrhythmogenicity of Fabry cardiomyopathy, by comparing device usage in patients with Fabry cardiomyopathy and sarcomeric HCM...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijapurapu, Ravi, Bradlow, William, Leyva, Francisco, Moon, James C., Zegard, Abbasin, Lewis, Nigel, Kotecha, D., Jovanovic, Ana, Hughes, Derralynn A., Woolfson, Peter, Steeds, Richard P., Geberhiwot, Tarekegn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734227/
https://www.ncbi.nlm.nih.gov/pubmed/34991670
http://dx.doi.org/10.1186/s13023-021-02133-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734227/
https://www.ncbi.nlm.nih.gov/pubmed/34991670
http://dx.doi.org/10.1186/s13023-021-02133-4

Ejemplares similares